NEW ZEALAND GAZETTE, No. 32

3 FEBRUARY 2005

Podophyllum peltatum; for internal use; for external use for
the treatment of anogenital warts; for other external use
in medicines containing more than 20% of podophyllin
Podophyllotoxin; for internal use; for external use for the
treatment of anogenital warts; for other external use in
medicines containing more than 1%
Polyacrilamide; in injections or implantations for tissue
augmentation or cosmetic use
Polylactic acid; in injections or implantations for tissue
augmentation or cosmetic use
Poractant alfa
Pramocaine
Pregabalin
Pregnenolone
Prilocaine; for injection except when used as a local
anaesthetic by a dental therapist; except when specified
elsewhere in the Schedule
Prochlorperazine; except when specified elsewhere in the
Schedule; except when sold for the treatment of nausea
associated with emergency contraception by pharmacists
or nurses accredited to sell levonorgestrel for emergency
contraception
Propantheline
Protamine sulfate
Quinisocaine
Sabadilla; except when specified elsewhere in the Schedule
Sevelamer
Silver sulfadiazine; except for external use in packs
containing 50 grams or less Strontium ranelate
Strychnos spp
Tenofovir
Thiomesterone
Thiourea; except in medicines containing 0.1% or less
Trichloroacetic acid; except for external use in medicines
containing 12.5% or less for the treatment of warts other
than anogenital warts
Vardenafil
Ximelagatran

Schedule 2

Restricted Medicines

Ciclopirox; for dermal use in medicines containing more
than 2%
Diclofenac; in solid dose form containing 25 milligrams or
less and more than 12.5 milligrams per dose form in
packs of not more than 30 tablets or capsules
Erythryl tetranitrate

Fluconazole; for oral use in medicines which have received
the consent of the Minister or the Director-General to
their distribution as restricted medicines and are
sold in the manufacturer’s original pack containing 150
milligrams or less as a single dose for the treatment of
vaginal candidiasis

Fluorides; in pastes, gels or powders for cleaning the teeth
containing more than 0.1%
Glyceryl trinitrate; for oral or sublingual use
Haemophilus influenzae vaccine; in oral vaccines for the
prophylaxis of bacterial complications of colds
Hyoscine butylbromide; for oral use in medicines containing
not more than 10 milligrams per dose form and in packs
containing not more than 20 tablets or capsules
Mannityl hexanitrate
Pneumococcal vaccine; in oral vaccines for the prophylaxis
of bacterial complications of colds

Podophyllum emodi; for external use for the treatment
of warts other than anogenital warts in medicines
containing 20% or less and more than 10% of
podophyllin
Podophyllum peltatum; for external use for the treatment
of warts other than anogenital warts in medicines
containing 20% or less and more than 10% of
podophyllin
Podophyllotoxin; for external use for the treatment of warts
other than anogenital warts in medicines containing 1%
or less and more than 0.5%
Prochlorperazine; in packs containing not more than
10 tablets for the treatment of nausea associated with
migraine
Salicylic acid; in medicines containing more than 40%
Sodium picosulfate; in preparations for bowel cleansing
prior to diagnostic, medical or surgical procedures

Schedule 3

Pharmacy-only Medicines

Acetylcysteine; for oral use in medicines containing more
than 1 gram per recommended daily dose
Aciclovir; for external use for the treatment of herpes
labialis except in medicines containing 5% or less and
in tubes containing 3 grams or less
Amethocaine; for external use in medicines containing 10%
or less and more than 2%
Atropa belladonna; for external use in medicines containing
0.03% of the alkaloids of belladonna; for oral use in
liquid form in medicines containing 0.03% or less and
0.3 milligrams or less per dose and not more than 1.2
milligrams per recommended daily dose of the alkaloids
of belladonna or in solid dose form in medicines
containing 0.3 milligrams or less per dose form and
not more than 1.2 milligrams per recommended daily
dose of the alkaloids of belladonna
Atropine; for oral use in liquid form in medicines containing
0.03% or less and 0.3 milligrams or less per dose and
not more than 1.2 milligrams per recommended daily
dose or in solid dose form in medicines containing
0.3 milligrams or less per dose form and not more than 1.2
milligrams per recommended daily dose; in medicines
containing atropine sulfate for the treatment of
organophosphorous poisoning either in packs of up to
20 tablets containing 0.6 milligrams or less per tablet
or in injections in packs of 5 or less containing 0.6
milligrams per millilitre or less; except when used as an
antidote in a device designed for self-injection; except
when sold by licencees under the Toxic Substances
Regulations

Beclomethasone; in aqueous nasal sprays delivering up
to 50 micrograms per actuation when the maximum
recommended daily dose is not greater than 400
micrograms and the medicine has received the consent
of the Minister or the Director-General to its distribution
as a pharmacy-only medicine

Benzocaine; for external use in medicines containing 10%
or less and more than 2%
Benzydamine; for external use
Bifonazole; for external use except in medicines for tinea
pedis only or in shampoos containing 1% or less

Budesonide; in aqueous nasal sprays delivering up to
50 micrograms per actuation when the maximum
recommended daily dose is not greater than 400
micrograms and the medicine has received the consent
of the Minister or the Director-General to its distribution
as a pharmacy-only medicine

Ciclopirox; for dermal use in medicines containing 2% or
less except in medicines for tinea pedis only